NEURAXIS, INC. Deferred Income Tax Expense (Benefit)
NEURAXIS, INC. (NRXS) reported Deferred Income Tax Expense (Benefit) of -$2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-19
- NEURAXIS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$2.00M.
- NEURAXIS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$2.20M.
- NEURAXIS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$3.22M.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$2.00M 10-K · filed 2026-03-19 | |
| 2024-12-31 | -$2.20M 10-K · filed 2026-03-19 | -$1.60M 10-K · filed 2025-03-20 |
| 2023-12-31 | -$3.22M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |